Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● Its low valuation, with P/E ratio at 5.76 and 5.81 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company shows low valuation levels, with an enterprise value at 0.38 times its sales.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.


Weaknesses

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company does not generate enough profits, which is an alarming weak point.

● The company is not the most generous with respect to shareholders' compensation.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.